Three drugs: Fosamax, Evista and Actonel dominate the osteoporosis treatment market, and a fourth drug, Boniva, recently became available.
Teva Pharmaceutical successfully fought Read the rest of this entry »
Teva Attacks Eli Lilly’s Patents for Evista
July 2, 2006
Leave a Comment » | 
Israel Related, News, Patents, pharmaceuticals and Biotechnology, Teva, Uncategorized, US Patent Office | 
Permalink
Posted by Dr Michael Factor
Teva to Produce Generic Version of Zoloft
July 2, 2006Teva has now received final approval to market a generic version of Pfizer’s Antidepressant, Zoloft®. The drug has 3 billion dollars of sales annually, and has been around for 14 years. Teva’s version will be available within weeks.
Zoloft® (sertraline HCl) is a selective serotonin Read the rest of this entry »
Leave a Comment » | Israel Related, News, Patents, pharmaceuticals and Biotechnology, Teva, Uncategorized | Permalink
Posted by Dr Michael Factor
Lencor and Lengo Trademarks Rejected as Potentially Misleading the Public
July 2, 2006In a recent ruling, on 25 June 2006, Dr. Meir Noam, the Israel Commissioner of Patents has upheld a decision of the Trademark Department not to allow registration of the marks Lencor and Lengo for domestic appliances. Read the rest of this entry »
Leave a Comment » | Israel IP, Israel Patent Office Rulings, Israel Related, Israel Trademark, News, Opinion, trademarks, Uncategorized | Permalink
Posted by Dr Michael Factor
